Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

3.0K
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Bi-objective Array Optimization Framework for Magnetocardiographic Source Imaging.

IEEE transactions on bio-medical engineering·2026
Same author

Abnormal Sialylation Promotes Chemotherapy Resistance in Bladder Cancer via the PI3K-AKT-mTOR Signaling Pathway.

Cancers·2026
Same author

Association of a data-driven nutrient risk score with incident rheumatoid arthritis in UK Biobank adults: a prospective cohort study.

Frontiers in immunology·2026
Same author

Diagnosis and management of mixed Chlamydia abortus and psittaci pneumonia guided by metagenomic next-generation sequencing: a case report.

BMC infectious diseases·2026
Same author

Associations between dietary inflammatory potential and COPD: the mediating role of inflammation.

Frontiers in nutrition·2026
Same author

From Label-Free Multiphoton Imaging to Pathological Reports: A Vision-Language Breast Cancer Margin Pathological Diagnosis System.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

MCT1 inhibition reprograms Treg metabolism via ABC transporters: implications for tumor immunity and the prognosis of acute myeloid leukemia patients.

European journal of medical research·2026
Same journal

Delayed bedtime on workdays is associated with an increased prevalence of gallstones: a population-based study.

European journal of medical research·2026
Same journal

Salvianolic acid B attenuates post-cardiac arrest cerebral ischemia-reperfusion injury via activation of the Nrf2 signaling pathway.

European journal of medical research·2026
Same journal

Clinical value of sputum galactomannan testing in the diagnosis of invasive pulmonary aspergillosis among chronic obstructive pulmonary disease patients.

European journal of medical research·2026
Same journal

Integrative analysis reveals luteolin's molecular targets and mechanisms in pancreatic cancer treatment.

European journal of medical research·2026
Same journal

Non-linear association between cardiometabolic index and helicobacter pylori infection: a cross-sectional study.

European journal of medical research·2026
See all related articles

Related Experiment Video

Updated: May 2, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.3K

Aberrant ADAM10 expression correlates with osteosarcoma progression.

Ren Zhao, Dongjing Ni, Yi Tian

  • 1Department of Orthopedics, Daping Hospital, Third Military Medical University, No, 10 Changjiang Road, Daping, Yuzhong District, Chongqing 400042, China. nibingxi@yahoo.com.

European Journal of Medical Research
|February 20, 2014
PubMed
Summary
This summary is machine-generated.

ADAM10 protein is crucial in osteosarcoma progression and may be a therapeutic target. Multinucleated giant cells in osteosarcoma are angiogenic tumor cells, not osteoclasts, involving ADAM10/Notch1 signaling.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

6.7K
Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
02:35

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

1.7K

Related Experiment Videos

Last Updated: May 2, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.3K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

6.7K
Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
02:35

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study

Published on: March 22, 2024

1.7K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Osteosarcoma, a common bone cancer, exhibits rapid progression.
  • The Notch signaling pathway is implicated in osteosarcoma development.
  • ADAM10, a Notch receptor sheddase, has an uninvestigated role in osteosarcoma.

Purpose of the Study:

  • Investigate the role of ADAM10 in osteosarcoma progression.
  • Clarify the identity of multinucleated giant cells in giant cell-rich osteosarcoma.
  • Examine the expression of CD31 in different osteosarcoma stages.

Main Methods:

  • Tissue chip samples from 40 nonmetastatic osteosarcoma cases were analyzed.
  • Immunofluorescence staining was used to detect ADAM10, activated Notch1 (NICD), and CD31.
  • Osteoclasts were identified using tartrate-resistant acid phosphatase (TRAP) staining.

Main Results:

  • ADAM10 expression significantly increased with osteosarcoma progression and in osteoblastic subtypes.
  • NICD and CD31 expression showed no significant alteration across pathological stages.
  • Multinucleated giant cells coexpressed CD31, ADAM10, and NICD, but were TRAP-negative.

Conclusions:

  • ADAM10 is important in osteosarcoma progression and a potential therapeutic target.
  • Multinucleated giant cells are angiogenic tumor cells, not osteoclasts.
  • ADAM10/Notch1 signaling activation is involved in these tumor cells.